Figures & data
Figure 1 Flowchart depicting literature search and study selection.
![Figure 1 Flowchart depicting literature search and study selection.](/cms/asset/1d3acfc6-bd34-4e8f-81d0-b7dffd93ecf1/dndt_a_152256_f0001_b.jpg)
Table 1 Characteristics of individual studies included in the meta-analysis
Table 2 Genotypic and allelic distributions of the MMP-3 polymorphism in ischemic stroke patients and controls
Figure 2 Forest plot for included studies examining the association between rs679620 and ischemic stroke risk under the dominant model (AA + GA vs GG).
![Figure 2 Forest plot for included studies examining the association between rs679620 and ischemic stroke risk under the dominant model (AA + GA vs GG).](/cms/asset/47f17f41-c2b5-4b9d-9164-e864a7dd235e/dndt_a_152256_f0002_c.jpg)
Table 3 Meta-analysis for the association of the MMP-3 polymorphisms rs679620 and rs3025058 with ischemic stroke risk
Figure 3 Forest plot for included studies examining the association between rs3025058 and ischemic stroke risk (5A5A + 6A5A vs 6A6A).
Abbreviation: OR, odds ratio.
![Figure 3 Forest plot for included studies examining the association between rs3025058 and ischemic stroke risk (5A5A + 6A5A vs 6A6A).](/cms/asset/c21ae8da-d6a2-422b-bd21-201e11016c00/dndt_a_152256_f0003_c.jpg)
Figure 4 Sensitivity analysis for the association between rs3025058 and ischemic stroke risk (5A5A + 6A5A vs 6A6A).
![Figure 4 Sensitivity analysis for the association between rs3025058 and ischemic stroke risk (5A5A + 6A5A vs 6A6A).](/cms/asset/3da47b6b-b4d2-493b-bccb-f102f2a026ea/dndt_a_152256_f0004_b.jpg)